Dear Colleagues, Welcome to my PES monthly President’s Newsletters! I want to begin by expressing my heartfelt gratitude to Dr.…
More Articles
Obituary –William Valentine Tamborlane Jr. William V. (Bill) Tamborlane was born on August 25, 1946, in the Bronx, New York, to William and Eleanor Tamborlane. He attended Bergen Catholic…
Dear Colleagues, This introduction to the President’s Newsletter will be brief as we make the final preparations for the 2026 Annual Meeting. The Program Committee has organized a terrific conference…
New Drugs and Therapeutics Update: JUXTAPID® (lomitapide) capsules Prepared by Daniel Mak, MD On March 3rd, 2026, the FDA approved and expanded indication for JUXTAPID (lomitapide) capsules for pediatric use in children…
Felicia Cooper, MD I am a third-year pediatric endocrinology fellow at Nemours Children’s Health in Orlando, Florida. I will be staying at my current institution as a pediatric endocrinologist starting…
Jordin Frasch, DNP, APRN, CPNP-PC Jordin Frasch, DNP, APRN, CPNP-PC is a Pediatric Nurse Practitioner at Cedars-Sinai Guerin Children’s in the Department of Pediatric Endocrinology in Los Angeles, California. Jordin…
Then and Now: This Month in Endocrine History Submitted by Evan Graber, DO In 1963, Arnold H. Kadish reported on the use of a “servomechanism for glucose monitoring and control,” the first…
Dear Colleagues, “Beware the Ides of March” warned a soothsayer to Julius Caesar in William Shakespeare’s Julius Caesar. The prophecy proved fatal when Caesar was assassinated in mid-March. While the specificity…
New Drugs and Therapeutics Update: Sogroya® (somapacitan-beco) Injection Prepared by Daniel Mak, MD; Edited by Neha Patel, DO On February 27th, 2026, the FDA approved Sogroya® (somapacitan-beco) for three new…
Depo-Provera® and Increased Risk of Meningioma: FDA-Label Update Written by: Anna Ryabets-Lienhard, DO as part of Drugs and Therapeutics Committee In December 2025, the U.S. Food and Drug Administration (FDA) approved…
Navepegritide (Yuviwel®) for Children with Achondroplasia: New Drugs and Therapeutics Written by Anna Ryabets-Lienhard, DO Edited by Neha Patel, DO and Emily Breidbart, MD On February 27th, 2026, the FDA…